Short answer · Medically reviewed summary · Last updated: 2026-04-06
Erdheim-Chester Disease (ECD) is an ultra-rare multisystem histiocytic neoplasm with an estimated prevalence of approximately 0.5 to 1 per 100,000 individuals, though precise global numbers remain difficult to determine. Incidence and Demographics Because Erdheim-Chester Disease is extremely rare, true incidence rates are not definitively established, though it is categorized as an ultra-rare condition. Current clinical literature suggests a slight male predominance, with a ratio often cited as 3:1 in many reported cohorts.
What is the prevalence of Erdheim Chester Disease?
Prevalence of Erdheim Chester Disease: how many people are affected worldwide, differences by sex and region, with sources.
Erdheim-Chester Disease (ECD) is an ultra-rare multisystem histiocytic neoplasm with an estimated prevalence of approximately 0.5 to 1 per 100,000 individuals, though precise global numbers remain difficult to determine.
Incidence and Demographics
Because Erdheim-Chester Disease is extremely rare, true incidence rates are not definitively established, though it is categorized as an ultra-rare condition. Current clinical literature suggests a slight male predominance, with a ratio often cited as 3:1 in many reported cohorts. While Erdheim-Chester Disease can present at any age, it is primarily diagnosed in adults, typically between the ages of 40 and 70, with pediatric cases being exceptionally uncommon.
Geographic and Diagnostic Challenges
There are no known specific geographic or ethnic clusters associated with the development of Erdheim-Chester Disease. A significant challenge in determining accurate prevalence is the high probability of underdiagnosis or misdiagnosis; patients often present with non-specific skeletal pain or systemic symptoms that may be attributed to other conditions for years before a definitive biopsy confirms the presence of foamy histiocytes characteristic of this disease. Because the condition is often overlooked, the actual number of people living with Erdheim-Chester Disease is likely higher than current diagnostic registries suggest.
Real-World Insights
While formal medical registries provide a clinical baseline, community-driven platforms like DiseaseMaps.org offer vital, complementary data. The 74 individuals currently connected through the DiseaseMaps community provide a crucial real-world perspective on the diagnostic journey and the lived experience of those managing this rare condition, helping to bridge the gap between clinical statistics and the patient reality.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- OMIM (Online Mendelian Inheritance in Man)
- Erdheim-Chester Disease Global Alliance
